250 related articles for article (PubMed ID: 15959915)
1. p63 Expression of clear myoepithelial cells in epithelial-myoepithelial carcinoma of the salivary gland: a useful marker for naked myoepithelial cells in cytology.
Kawahara A; Harada H; Yokoyama T; Kage M
Cancer; 2005 Aug; 105(4):240-5. PubMed ID: 15959915
[TBL] [Abstract][Full Text] [Related]
2. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
3. Distribution of p63, a novel myoepithelial marker, in fine-needle aspiration biopsies of the breast: an analysis of 82 samples.
Reis-Filho JS; Milanezi F; Amendoeira I; Albergaria A; Schmitt FC
Cancer; 2003 Jun; 99(3):172-9. PubMed ID: 12811858
[TBL] [Abstract][Full Text] [Related]
4. Myoepithelial cell cocktail (p63+SMA) for the evaluation of sclerosing breast lesions.
Pavlakis K; Zoubouli C; Liakakos T; Messini I; Keramopoullos A; Athanassiadou S; Kafousi M; Stathopoulos EN
Breast; 2006 Dec; 15(6):705-12. PubMed ID: 16384708
[TBL] [Abstract][Full Text] [Related]
5. Cytopathological features of an epithelial-myoepithelial carcinoma with predominant clear myoepithelial cells in the parotid gland.
Kawahara A; Harada H; Yokoyama T; Kage M
Diagn Cytopathol; 2004 Apr; 30(4):280-3. PubMed ID: 15048967
[TBL] [Abstract][Full Text] [Related]
6. Adenomyoepithelial tumours and myoepithelial carcinomas of the breast--a spectrum of monophasic and biphasic tumours dominated by immature myoepithelial cells.
Hungermann D; Buerger H; Oehlschlegel C; Herbst H; Boecker W
BMC Cancer; 2005 Jul; 5():92. PubMed ID: 16050957
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of p63 in pleomorphic adenomas and carcinomas ex-pleomorphic adenomas of salivary glands.
Genelhu MC; Gobbi H; Soares FA; Campos AH; Ribeiro CA; Cassali GD
Oral Oncol; 2006 Feb; 42(2):154-60. PubMed ID: 16256413
[TBL] [Abstract][Full Text] [Related]
8. Naked nuclei revisited: p63 Immunoexpression.
Reis-Filho JS; Albergaria A; Milanezi F; Amendoeira I; Schmitt FC
Diagn Cytopathol; 2002 Sep; 27(3):135-8. PubMed ID: 12203858
[TBL] [Abstract][Full Text] [Related]
9. Antibodies targeting p63 react specifically in the cytoplasm of breast epithelial cells exhibiting secretory differentiation.
Bratthauer GL; Saenger JS; Strauss BL
Histopathology; 2005 Dec; 47(6):611-6. PubMed ID: 16324199
[TBL] [Abstract][Full Text] [Related]
10. Cytologic differential diagnosis of papillary pattern in breast aspirates: correlation with histology.
Nayar R; De Frias DV; Bourtsos EP; Sutton V; Bedrossian C
Ann Diagn Pathol; 2001 Feb; 5(1):34-42. PubMed ID: 11172205
[TBL] [Abstract][Full Text] [Related]
11. [Myoepithelial differentiation markers in salivary gland neoplasia].
Scarpellini F; Marucci G; Foschini MP
Pathologica; 2001 Dec; 93(6):662-7. PubMed ID: 11785118
[TBL] [Abstract][Full Text] [Related]
12. Immunolocalization of three novel smooth muscle-specific proteins in salivary gland pleomorphic adenoma: assessment of the morphogenetic role of myoepithelium.
Savera AT; Gown AM; Zarbo RJ
Mod Pathol; 1997 Nov; 10(11):1093-100. PubMed ID: 9388059
[TBL] [Abstract][Full Text] [Related]
13. Sebaceous epithelial-myoepithelial carcinoma of the salivary gland: clinicopathologic and immunohistochemical analysis of 6 cases of a new histologic variant.
Shinozaki A; Nagao T; Endo H; Kato N; Hirokawa M; Mizobuchi K; Komatsu M; Igarashi T; Yokoyama M; Masuda S; Sano K; Izumi M; Fukayama M; Mukai K
Am J Surg Pathol; 2008 Jun; 32(6):913-23. PubMed ID: 18425042
[TBL] [Abstract][Full Text] [Related]
14. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE
J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-myoepithelial carcinoma of the bronchus.
Ryska A; Kerekes Z; Hovorková E; Barton P
Pathol Res Pract; 1998; 194(6):431-5; discussion 436-8. PubMed ID: 9689652
[TBL] [Abstract][Full Text] [Related]
16. [Metallothionein expression and its significance in salivary gland tumors].
Gao Y; Han Z; Liu X
Zhonghua Kou Qiang Yi Xue Za Zhi; 1997 Sep; 32(5):282-4. PubMed ID: 11189287
[TBL] [Abstract][Full Text] [Related]
17. False-positives in fine-needle aspiration cytology of breast disease can be reduced with p63 immunostaining--a preliminary report.
Nagao T; Bando Y; Sasa M; Morimoto T; Sano N; Hirose T; Tangoku A
Anticancer Res; 2006; 26(6B):4373-7. PubMed ID: 17201157
[TBL] [Abstract][Full Text] [Related]
18. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms.
Ramalho LN; Ribeiro-Silva A; Cassali GD; Zucoloto S
Vet Pathol; 2006 Jul; 43(4):424-9. PubMed ID: 16846983
[TBL] [Abstract][Full Text] [Related]
19. p63 immunostaining in destained bronchoscopic cytological specimens.
Shtilbans V; Szporn AH; Wu M; Burstein DE
Diagn Cytopathol; 2005 Apr; 32(4):198-203. PubMed ID: 15754365
[TBL] [Abstract][Full Text] [Related]
20. Epithelial-myoepithelial carcinoma with high grade transformation.
Roy P; Bullock MJ; Perez-Ordoñez B; Dardick I; Weinreb I
Am J Surg Pathol; 2010 Sep; 34(9):1258-65. PubMed ID: 20679885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
